Gowling WLG has again acted for Getinge, a global medical technology company, this time on its acquisition of 100% of the shares of Quadralene, a global manufacturer of decontamination products for the health care and dental sector for an initial £17 million, plus contingent deferred consideration up to £ 2.3 million.
Getinge is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. The company employs more than 10,000 people and has operations in 38 countries.
Quadralene is a UK based company founded in 1930 which designs, commercialises, manufactures and delivers decontamination products globally. Approximately 75% of its revenue comes from the health care and dental sector and Getinge is its largest customer with 43% of Quadralene's revenue.
Corporate partner Ian Piggin led a cross-firm Gowling WLG team advising on the transaction, supported by senior associate Roisin Bergin and trainee solicitor Eleanor Craven. Partner Ben Stansfield led on the environmental and sustainability related advice.
Ian said: "Our experience in the healthcare sector and expertise in environmental and sustainability law were key to supporting Getinge on this important acquisition.
"It is fantastic to work on an acquisition that will genuinely bring added piece of mind and efficiency where the delivery of sanitised healthcare facilities is concerned in line with our client's mission to reduce hospital acquired infections."
Eric Bielen, Corporate VP Business Development and M&A from Getinge added: "Quadralene has a great reputation in the field of decontamination, and we are excited that they join Getinge as the future cornerstone of our newly created Centre of Excellence dedicated to chemistry and instrument disinfection. We were pleased to be supported by the team at Gowling WLG on this important acquisition."